Incidence, clinical characteristics and early treatment outcome in Indian patients of childhood acute lymphoblastic leukemia with ALL-1 gene rearrangement-Reference-Cited by-同舟云学术

Incidence, clinical characteristics and early treatment outcome in Indian patients of childhood acute lymphoblastic leukemia with ALL-1 gene rearrangement

Published:2001-08 Issue:8 Volume:25 Page:693-698
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Sazawal Sudha,Gurbuxani Sandeep,Bhatia Kishor,Khattar Anshu,Raina Vinod,Arya Laxman Singh,Vats Tribhawan,Magrath Ian,Bhargava Manorama

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference29 articles.

1. Pattern of subtypes of acute lymphoblastic leukemia in India;Kamat;Leuk. Res.,1985

2. Immunological subtypes of acute lymphoblastic leukemia in North India;Bhargava;Leuk. Res.,1988

3. Immunophenotyping of acute lymphoblastic leukemia in Madras, India;Rajalekshmy;Leuk. Res.,1994

4. Acute lymphoblastic leukemia: end result analysis of treatment and prognostic factors in Indian patients;Advani;Am. J. Hematol.,1993

5. Stem cell origin of leukemia and curability;Greaves;Br. J. Cancer,1993

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology of childhood and adolescent cancer in Bangladesh, 2001–2014;BMC Cancer;2016-02-15

2. Detection and Clinical Relevance of BCR-ABL Fusion Gene in Childhood T-lineage Acute Lymphoblastic Leukemia;Journal of Pediatric Hematology/Oncology;2009-11

3. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year peroid;European Journal of Cancer;2005-07

4. Identification of various MLL gene aberrations that lead to MLL gene mutation in patients with acute lymphoblastic leukemia (ALL) and infants with acute leukemia;Leukemia Research;2005-05

5. Clonal T-cell Receptor γ and δ Gene Rearrangements in T-cell Acute Lymphoblastic Leukemia at Diagnosis: Predictor of Prognosis and Response to Chemotherapy;Leukemia & Lymphoma;2004-01